STERIS plc (NYSE: STE) is -15.04% lower on its value in year-to-date trading and has touched a low of $192.40 and a high of $255.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The STE stock was last observed hovering at around $205.42 in the last trading session, with the day’s gains setting it 1.37% off its average median price target of $253.00 for the next 12 months. It is also 29.9% off the consensus price target high of $295.00 offered by 7 analysts, but current levels are 13.84% higher than the price target low of $240.00 for the same period.
Currently trading at $206.79, the stock is 0.97% and -4.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.46 million and changing 0.67% at the moment leaves the stock -9.07% off its SMA200. STE registered -0.58% loss for a year compared to 6-month loss of -11.91%. The firm has a 50-day simple moving average (SMA 50) of $5.21 and a 200-day simple moving average (SMA200) of $24.96.
The stock witnessed a -2.10% gain in the last 1 month and extending the period to 3 months gives it a -16.12%, and is -0.20% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.89% over the week and 2.67% over the month.
STERIS plc (STE) has around 16422 employees, a market worth around $20.48B and $4.59B in sales. Current P/E ratio is 86.38 and Fwd P/E is 22.08. Profit margin for the company is 5.30%. Distance from 52-week low is 7.48% and -19.20% from its 52-week high. The company has generated returns on investments over the last 12 months (3.70%).
STERIS plc (STE) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for STERIS plc (STE) is a “Buy”. 7 analysts offering their recommendations for the stock have an average rating of 1.60, where 1 rate it as a Hold and 0 think it is a “Overweight”. 6 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
STERIS plc is expected to release its quarterly report on 11/02/2022.The EPS is expected to shrink by -46.40% this year.
STERIS plc (STE) Top Institutional Holders
The shares outstanding are 100.10M, and float is at 99.78M with Short Float at 1.43%.
STERIS plc (STE) Insider Activity
A total of 36 insider transactions have happened at STERIS plc (STE) in the last six months, with sales accounting for 21 and purchases happening 15 times. The most recent transaction is an insider sale by Zangerle John Adam ,the company’sSr. VP, Gen Counsel, and Sec.. SEC filings show that Zangerle John Adam sold 2,659 shares of the company’s common stock on Jun 15 at a price of $205.31 per share for a total of $0.55 million. Following the sale, the insider now owns 27936.0 shares.
STERIS plc disclosed in a document filed with the SEC on Apr 20 that Zangerle John Adam (Sr. VP, Gen Counsel, and Sec.) sold a total of 8,000 shares of the company’s common stock. The trade occurred on Apr 20 and was made at $255.48 per share for $2.04 million. Following the transaction, the insider now directly holds 31023.0 shares of the STE stock.
Still, SEC filings show that on Apr 07, TOKICH MICHAEL J (Sr. Vice Pres., CFO) disposed off 8,000 shares at an average price of $250.00 for $2.0 million. The insider now directly holds 38,444 shares of STERIS plc (STE).
STERIS plc (STE): Who are the competitors?
The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading 2.91% up over the past 12 months and Danaher Corporation (DHR) that is -10.16% lower over the same period. Becton Dickinson and Company (BDX) is -2.37% down on the 1-year trading charts.